Overview

Safety of Treatment of Uterine Fibroids With Asoprisnil

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the long-term safety of asoprisnil in women with symptomatic uterine fibroids who completed the 6 month Study C02-037.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott